These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26280926)

  • 21. Generic versus branded enoxaparin in the prevention of venous thromboembolism following major abdominal surgery: report of an exploratory clinical trial.
    Gomes M; Ramacciotti E; Henriques AC; Araujo GR; Szultan LA; Miranda F; Thethi I
    Clin Appl Thromb Hemost; 2011; 17(6):633-9. PubMed ID: 21949036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative analysis of antithrombin III binding site in low molecular weight heparins by exhausetive heparinases digestion and capillary electrophoresis.
    Zhang M; Li G; Zhang Y; Kang J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Nov; 1068-1069():78-83. PubMed ID: 29031112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences of present recommendations and guidelines for generic low-molecular-weight heparins: is there room for harmonization.
    Harenberg J
    Clin Appl Thromb Hemost; 2011; 17(6):E158-64. PubMed ID: 21406409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality control and product differentiation of LMWHs marketed in China using
    Jiang H; Li X; Ma M; Shi X; Wu X
    J Pharm Biomed Anal; 2022 Feb; 209():114472. PubMed ID: 34864594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural features of low-molecular-weight heparins affecting their affinity to antithrombin.
    Bisio A; Vecchietti D; Citterio L; Guerrini M; Raman R; Bertini S; Eisele G; Naggi A; Sasisekharan R; Torri G
    Thromb Haemost; 2009 Nov; 102(5):865-73. PubMed ID: 19888521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of currently marketed heparin products: key tests for LMWH quality assurance.
    Ye H; Toby TK; Sommers CD; Ghasriani H; Trehy ML; Ye W; Kolinski RE; Buhse LF; Al-Hakim A; Keire DA
    J Pharm Biomed Anal; 2013 Nov; 85():99-107. PubMed ID: 23917037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of hydrophilic interaction chromatography with quadruple time-of-flight mass spectrometry for heparin and low molecular weight heparin disaccharide analysis.
    Ouyang Y; Wu C; Sun X; Liu J; Linhardt RJ; Zhang Z
    Rapid Commun Mass Spectrom; 2016 Jan; 30(2):277-84. PubMed ID: 26689158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parent heparin and daughter LMW heparin correlation analysis using LC-MS and NMR.
    Liu X; St Ange K; Wang X; Lin L; Zhang F; Chi L; Linhardt RJ
    Anal Chim Acta; 2017 Apr; 961():91-99. PubMed ID: 28224913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomarkers and coagulation tests for assessing the biosimilarity of a generic low-molecular-weight heparin: results of a study in healthy subjects with enoxaparin.
    Kuczka K; Harder S; Picard-Willems B; Warnke A; Donath F; Bianchini P; Parma B; Blume H
    J Clin Pharmacol; 2008 Oct; 48(10):1189-96. PubMed ID: 18716314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overview on guidelines and recommendations for generic low-molecular-weight heparins.
    Harenberg J
    Thromb Res; 2011 Feb; 127 Suppl 3():S100-4. PubMed ID: 21262425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative PCR and disaccharide profiling to characterize the animal origin of low-molecular-weight heparins.
    Houiste C; Auguste C; Macrez C; Dereux S; Derouet A; Anger P
    Clin Appl Thromb Hemost; 2009 Feb; 15(1):50-8. PubMed ID: 18805847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Scientific considerations in the review and approval of generic enoxaparin in the United States.
    Lee S; Raw A; Yu L; Lionberger R; Ya N; Verthelyi D; Rosenberg A; Kozlowski S; Webber K; Woodcock J
    Nat Biotechnol; 2013 Mar; 31(3):220-6. PubMed ID: 23471071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Low-Molecular-Weight Heparins Prepared From Bovine Lung Heparin and Porcine Intestine Heparin.
    Guan Y; Xu X; Liu X; Sheng A; Jin L; Linhardt RJ; Chi L
    J Pharm Sci; 2016 Jun; 105(6):1843-1850. PubMed ID: 27238483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New and generic anticoagulants and biosimilars: safety considerations.
    Kalodiki E; Fareed J
    Clin Appl Thromb Hemost; 2011 Apr; 17(2):136-9. PubMed ID: 21159711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on Brazilian biosimilar enoxaparins.
    Vilanova E; Glauser BF; Oliveira SM; Tovar AM; Mourão PA
    Expert Rev Hematol; 2016 Nov; 9(11):1015-1021. PubMed ID: 27680213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liquid chromatography-diode array detection-mass spectrometry for compositional analysis of low molecular weight heparins.
    Wang Z; Li D; Sun X; Bai X; Jin L; Chi L
    Anal Biochem; 2014 Apr; 451():35-41. PubMed ID: 24530286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel method for the determination of average molecular weight of natural polymers based on 2D DOSY NMR and chemometrics: Example of heparin.
    Monakhova YB; Diehl BWK; Do TX; Schulze M; Witzleben S
    J Pharm Biomed Anal; 2018 Feb; 149():128-132. PubMed ID: 29112901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fragment profiling of low molecular weight heparins using reversed phase ion pair liquid chromatography-electrospray mass spectrometry.
    Xu X; Li D; Chi L; Du X; Bai X; Chi L
    Carbohydr Res; 2015 Apr; 407():26-33. PubMed ID: 25701653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative studies on biological activity of generic and branded enoxaparin in vivo and vitro.
    Tan X; Cui H
    Blood Coagul Fibrinolysis; 2015 Oct; 26(7):805-10. PubMed ID: 26270263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversed-phase ion-pair ultra-high-performance-liquid chromatography-mass spectrometry for fingerprinting low-molecular-weight heparins.
    Langeslay DJ; Urso E; Gardini C; Naggi A; Torri G; Larive CK
    J Chromatogr A; 2013 May; 1292():201-10. PubMed ID: 23352830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.